A detailed history of Fagan Associates, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Fagan Associates, Inc. holds 141,973 shares of PFE stock, worth $3.8 Million. This represents 0.72% of its overall portfolio holdings.

Number of Shares
141,973
Previous 7,460 1803.12%
Holding current value
$3.8 Million
Previous $208,000 1875.0%
% of portfolio
0.72%
Previous 0.04%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$27.7 - $31.39 $3.73 Million - $4.22 Million
134,513 Added 1803.12%
141,973 $4.11 Million
Q2 2024

Aug 09, 2024

BUY
$25.26 - $29.6 $188,439 - $220,816
7,460 New
7,460 $208,000
Q1 2023

May 03, 2023

SELL
$39.39 - $51.28 $46,637 - $60,715
-1,184 Reduced 1.9%
61,209 $2.5 Million
Q4 2022

Jan 25, 2023

BUY
$41.75 - $54.5 $2.15 Million - $2.8 Million
51,397 Added 467.42%
62,393 $0
Q3 2022

Nov 01, 2022

BUY
$43.76 - $53.42 $43 - $53
1 Added 0.01%
10,996 $481,000
Q2 2022

Aug 03, 2022

BUY
$46.53 - $55.17 $9,399 - $11,144
202 Added 1.87%
10,995 $576,000
Q1 2022

May 06, 2022

SELL
$45.75 - $56.69 $27,358 - $33,900
-598 Reduced 5.25%
10,793 $559,000
Q4 2021

Feb 08, 2022

BUY
$41.32 - $61.25 $66,359 - $98,367
1,606 Added 16.41%
11,391 $673,000
Q3 2021

Nov 09, 2021

BUY
$39.25 - $50.42 $51,849 - $66,604
1,321 Added 15.61%
9,785 $421,000
Q2 2021

Aug 06, 2021

BUY
$35.91 - $40.68 $38,962 - $44,137
1,085 Added 14.7%
8,464 $331,000
Q1 2021

May 06, 2021

BUY
$33.49 - $37.77 $32,652 - $36,825
975 Added 15.22%
7,379 $267,000
Q4 2020

Feb 08, 2021

BUY
$33.47 - $42.56 $214,341 - $272,554
6,404 New
6,404 $236,000
Q1 2020

May 05, 2020

SELL
$27.03 - $38.62 $157,611 - $225,193
-5,831 Closed
0 $0
Q4 2019

Feb 07, 2020

SELL
$32.92 - $37.36 $4,115 - $4,670
-125 Reduced 2.1%
5,831 $228,000
Q3 2019

Nov 13, 2019

SELL
$32.49 - $42.13 $3,249 - $4,213
-100 Reduced 1.65%
5,956 $214,000
Q2 2019

Jul 12, 2019

BUY
$36.98 - $41.52 $32,727 - $36,745
885 Added 17.11%
6,056 $262,000
Q1 2019

May 01, 2019

BUY
$37.5 - $41.2 $3,750 - $4,120
100 Added 1.97%
5,171 $220,000
Q4 2018

Feb 05, 2019

BUY
$38.47 - $43.86 $1,154 - $1,315
30 Added 0.6%
5,071 $221,000
Q3 2018

Nov 06, 2018

BUY
$34.47 - $41.81 $173,763 - $210,764
5,041 New
5,041 $222,000
Q1 2018

May 08, 2018

SELL
$31.91 - $37.02 $1.17 Million - $1.36 Million
-36,813 Closed
0 $0
Q4 2017

Feb 09, 2018

BUY
$33.26 - $35.29 $12,040 - $12,774
362 Added 0.99%
36,813 $1.33 Million
Q3 2017

Nov 13, 2017

BUY
$31.0 - $34.15 $104,253 - $114,846
3,363 Added 10.16%
36,451 $1.3 Million
Q2 2017

Aug 07, 2017

BUY
N/A
33,088
33,088 $1.11 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Fagan Associates, Inc. Portfolio

Follow Fagan Associates, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fagan Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Fagan Associates, Inc. with notifications on news.